New Cancer Antibody Approved by Brazil’s Anvisa

Lung Cancer Treatment Enters a New Era: The Promise of Antibody Therapies and Personalized Medicine Every two minutes, someone in the United States receives a lung cancer diagnosis. But a recent approval by Brazil’s Anvisa signals a potential turning point in the fight against this devastating disease. While the immediate news focuses on a new … Read more

Weight Loss Pens & Neurological Issues: 4 SC Cases

The Looming Shadow of GLP-1s: Beyond Weight Loss, a Neurological and Systemic Health Crisis? Over 14 million Americans are now prescribed GLP-1 receptor agonists – drugs initially designed for diabetes, but rapidly adopted for weight loss. While hailed as a breakthrough, a growing wave of reports, particularly from Brazil, is revealing a darker side: a … Read more